• Home/
  • News articles
Consultation: Medicinal Cannabis Cost Recovery Framework
13 March 2020

The Office of Drug Control (ODC) is seeking comments from interested parties on the proposed Medicinal Cannabis Cost Recovery Framework. Closing date: 20 March 2020

Single Licence Model Consultation: Closing date for submissions
22 January 2020

Submissions in response to the Office of Drug Control's (ODCs) Consultation on Single Licence Model close COB Monday 3 Feb

Implementation of the Review of the Narcotic Drugs Act 1967 (Cth)
17 December 2019
The Office of Drug Control is implementing the 26 recommendations from the Report on the Review of the Narcotic Drugs Act 1967
Tabling of Report on the Review into the 2016 Medicinal Cannabis amendments to the Narcotic Drugs Act 1967
5 September 2019
Professor McMillan's Final Report on the Review of the Act was tabled in Parliament on Thursday 5 September 2019
Medicinal cannabis process clarification - from cultivation to manufacture
3 April 2019
A clarification of the processing rules around the timing of a medicinal cannabis licence and narcotics manufacturing licences
Review of the Narcotic Drugs Act 1967
4 March 2019
Professor John McMillan AO appointed to review and report on the operation of the Narcotic Drugs Act 1967
Review of the Narcotic Drugs Act 1967 - Public meetings
21 December 2018
The TGA will be hosting public meetings in February 2019 in Sydney, Brisbane and Melbourne
Claims about hemp and CBD oils misleading consumers
15 May 2018
False and misleading claims made by some companies
Export of medicinal cannabis and other changes to the Narcotic Drugs Regulation 2016
5 January 2018
Allowing the export of Australian-manufactured medicinal cannabis products
Message to the medical profession and patients: Office of Drug Control is not blocking imports of medicinal cannabis products.
28 August 2017
Doctors wishing to prescribe unregistered medicinal cannabis products under SAS Cat A